228 related articles for article (PubMed ID: 37391825)
1. Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy.
Guo L; Cai Y; Wang B; Zhang F; Zhao H; Liu L; Tao L
Eur J Med Res; 2023 Jun; 28(1):205. PubMed ID: 37391825
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.
Sun Y; Xiao Z; Chen Y; Xu D; Chen S
Front Cell Dev Biol; 2021; 9():822465. PubMed ID: 35178407
[No Abstract] [Full Text] [Related]
3. SNHG 12 and hsa-miR-140-5P may play an important role in the ceRNA network related to hypertrophic cardiomyopathy.
Zhai J; Guo F; Zhou X; Zhu K; Li J; Wang C
J Thorac Dis; 2023 Mar; 15(3):1353-1363. PubMed ID: 37065602
[TBL] [Abstract][Full Text] [Related]
4. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
Dong Q; Han Z; Tian L
Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
[TBL] [Abstract][Full Text] [Related]
5. lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.
Feng W; Han S
Oxid Med Cell Longev; 2022; 2022():1450610. PubMed ID: 35401927
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Construction of a Circular RNA-Associated Competing Endogenous RNA Network Identified Novel Circular RNAs in Hypertrophic Cardiomyopathy by Integrated Analysis.
Guo Q; Wang J; Sun R; He Z; Chen Q; Liu W; Wu M; Bao J; Liu Z; Wang J; Zhang Y
Front Genet; 2020; 11():764. PubMed ID: 32849787
[TBL] [Abstract][Full Text] [Related]
7. Identification of circulating hub long noncoding RNAs associated with hypertrophic cardiomyopathy using weighted correlation network analysis.
Guo Q; Wang J; Sun R; Gu W; He Z; Chen Q; Liu W; Chen Y; Wang J; Zhang Y
Mol Med Rep; 2020 Dec; 22(6):4637-4644. PubMed ID: 33174017
[TBL] [Abstract][Full Text] [Related]
8. Identification of circRNA-miRNA-mRNA regulatory network and its role in cardiac hypertrophy.
Gong K; Yang K; Xie T; Luo Y; Guo H; Tan Z; Chen J; Wu Q; Gong Y; Wei L; Luo J; Yao Y; Yang Y; Xie L
PLoS One; 2023; 18(3):e0279638. PubMed ID: 36952519
[TBL] [Abstract][Full Text] [Related]
9. Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.
Li X; Wang C; Zhang X; Liu J; Wang Y; Li C; Guo D
Hereditas; 2020 Oct; 157(1):42. PubMed ID: 33099311
[TBL] [Abstract][Full Text] [Related]
10. Identification of characteristic genes and construction of regulatory network in gallbladder carcinoma.
Shao H; Zhu J; Zhu Y; Liu L; Zhao S; Kang Q; Liu Y; Zou H
BMC Med Genomics; 2023 Oct; 16(1):240. PubMed ID: 37821907
[TBL] [Abstract][Full Text] [Related]
11. Reconstruction and analysis of potential biomarkers for hypertrophic cardiomyopathy based on a competing endogenous RNA network.
Chen JY; Xie ZX; Dai JZ; Han JY; Wang K; Lu LH; Jin JJ; Xue SJ
BMC Cardiovasc Disord; 2022 Sep; 22(1):422. PubMed ID: 36138345
[TBL] [Abstract][Full Text] [Related]
12. Identification of a miRNA-mRNA regulatory network for post-stroke depression: a machine-learning approach.
Qiu H; Shen L; Shen Y; Mao Y
Front Neurol; 2023; 14():1096911. PubMed ID: 37528851
[TBL] [Abstract][Full Text] [Related]
13. Osteomodulin is a Potential Genetic Target for Hypertrophic Cardiomyopathy.
Guo W; Feng W; Fan X; Huang J; Ou C; Chen M
Biochem Genet; 2021 Oct; 59(5):1185-1202. PubMed ID: 33715137
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair
Zhang Y; Zhao J; Jin Q; Zhuang L
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474063
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art.
Angelopoulos A; Oikonomou E; Vogiatzi G; Antonopoulos A; Tsalamandris S; Georgakopoulos C; Papanikolaou P; Lazaros G; Charalambous G; Siasos G; Vlachopoulos C; Tousoulis D
Curr Med Chem; 2021; 28(36):7400-7412. PubMed ID: 33820510
[TBL] [Abstract][Full Text] [Related]
16. A LncRNA-miRNA-mRNA ceRNA regulatory network based tuberculosis prediction model.
Feng J; Bian Q; He X; Zhang H; He J
Microb Pathog; 2021 Sep; 158():105069. PubMed ID: 34175436
[TBL] [Abstract][Full Text] [Related]
17. Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.
Zheng X; Yang Y; Huang Fu C; Huang R
Life Sci; 2021 Nov; 285():119956. PubMed ID: 34520765
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression.
Cao J; Yuan L
Front Cardiovasc Med; 2022; 9():946229. PubMed ID: 35990977
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM).
Wang L; Lu F; Xu J
Front Cardiovasc Med; 2021; 8():660372. PubMed ID: 34136543
[No Abstract] [Full Text] [Related]
20. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
Zhao W; Wu T; Zhan J; Dong Z
Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
